Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Announces Last Patients Complete Final Visit in NCX 470 Phase 3 Mont Blanc Glaucoma Trial

September 19, 2022

View Press Release Corporate presentation Contact us
Previous